PhRMA launches seven-figure ad campaign against 340B drug discount program

PhRMA, the leading pharmaceutical lobbying group, announced a new advertising push aimed at the federal 340B drug discount program.

The campaign, described as a seven-figure effort, is set to begin on Wednesday and will focus on highlighting concerns about the program’s recent expansion, according to a Bloomberg Law report.

The 340B program, which provides discounted medicines to certain health providers, has grown substantially in recent years, prompting industry groups to question its sustainability and impact on drug pricing.